Vial Announces the Addition of Dr. Egilius L.H. Spierings of MedVadis Research Corporation to their Central Nervous System Scientific Advisory Board

SAN FRANCISCO, March 8, 2023 /PRNewswire/ -- Vial, a global tech-first CRO providing next-generation clinical trial management services, announced the addition of Egilius L.H. Spierings, MD, Ph.D., to Vial's central nervous system (CNS) scientific advisory board (SAB). Dr. Spierings will...

Click to view original post